Media coverage about Intermolecular (NASDAQ:IMI) has trended somewhat positive on Monday, according to Accern. The research firm identifies positive and negative news coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Intermolecular earned a news sentiment score of 0.25 on Accern’s scale. Accern also assigned news stories about the semiconductor company an impact score of 45.1392465994816 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

These are some of the media headlines that may have effected Accern’s scoring:

Intermolecular (NASDAQ IMI) remained flat at $0.92 on Monday. 5,965 shares of the company traded hands. The firm has a 50-day moving average of $0.95 and a 200 day moving average of $0.95. The firm’s market capitalization is $45.59 million. Intermolecular has a 1-year low of $0.78 and a 1-year high of $1.29.

Separately, ValuEngine upgraded Intermolecular from a “strong sell” rating to a “sell” rating in a report on Monday, August 7th.

ILLEGAL ACTIVITY NOTICE: This article was first published by Watch List News and is the sole property of of Watch List News. If you are viewing this article on another domain, it was illegally stolen and reposted in violation of international copyright laws. The original version of this article can be accessed at https://www.watchlistnews.com/intermolecular-nasdaqimi-getting-somewhat-favorable-media-coverage-study-finds/1487803.html.

In related news, major shareholder Lloyd I. Miller III purchased 80,000 shares of the business’s stock in a transaction that occurred on Thursday, June 22nd. The shares were bought at an average price of $0.88 per share, for a total transaction of $70,400.00. Following the purchase, the insider now directly owns 70,368 shares of the company’s stock, valued at approximately $61,923.84. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders have acquired a total of 152,140 shares of company stock worth $131,786 in the last quarter. Company insiders own 15.20% of the company’s stock.

Intermolecular Company Profile

Intermolecular, Inc provides thin film solutions. The Company’s high productivity combinatorial (HPC) platform, which consists of its tempus processing tools, its automated characterization methods, and its Informatics analysis software, is purpose-built for research and development (R&D) using combinatorial process systems.

Insider Buying and Selling by Quarter for Intermolecular (NASDAQ:IMI)

Receive News & Ratings for Intermolecular Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intermolecular Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.